Matej Mikulic
Research expert covering health, pharma & medtech
Pharmaceutical industry in Southeast Asia - statistics & facts
Southeast Asia is often referred to as a pharmerging market due to its rising demand for pharmaceutical products, huge growth potential, and strong government initiatives and investments in the industry. In recent years, factors such as pricing pressure, patent protection, and regulatory frameworks have slowed down growth in established pharma markets such as Japan and Australia. Thus, major pharma companies are increasingly looking to pharmerging markets for their untapped potential.
